Rankings
▼
Calendar
MESO (Mesoblast Limited) Stock Financials & Earnings | Market Cap Arena
MESO
Mesoblast Limited
Mkt Cap
$2B
Healthcare
·
Biotechnology
·
🇦🇺 Australia
·
NASDAQ
Revenue (TTM)
$17M
Net Income (TTM)
-$102M
EPS (TTM)
-$0.84
Free Cash Flow (TTM)
-$59M
Gross Margin
-208.5%
Op. Margin
-639.5%
Net Margin
-593.9%
FCF Margin
-341.3%
P/S Ratio (TTM)
118.7x
P/E Ratio (TTM)
—
YoY Rev Growth
+191.4%
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$1M
-$9M
-$16M
Q2 23
$2M
-$14M
-$21M
Q3 23
$2M
-$11M
-$14M
Q4 23
$2M
-$13M
-$19M
Q1 24
$2M
-$8M
-$20M
Q2 24
$2M
-$8M
-$20M
Q3 24
$1M
-$10M
-$22M
Q4 24
$1M
-$10M
-$22M
Q1 25
$2M
-$2M
-$21M
Q2 25
$2M
-$2M
-$21M
Q3 25
$7M
-$16M
-$34M
Q4 25
$7M
-$16M
-$34M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
253.3x
—
Q2 23
266.6x
—
Q3 23
269.2x
—
Q4 23
272.2x
—
Q1 24
263.4x
—
Q2 24
273.5x
—
Q3 24
301.0x
—
Q4 24
346.0x
—
Q1 25
352.9x
—
Q2 25
360.1x
—
Q3 25
178.6x
—
Q4 25
118.7x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q3 23
-$16M
-$16M
Q4 23
-$16M
-$16M
Q1 24
-$14M
-$14M
Q2 24
-$13M
-$13M
Q3 24
$0
-$41K
Q4 24
$0
-$86K
Q1 25
-$10M
-$10M
Q2 25
-$10M
-$10M
Q3 25
-$13M
-$13M
Q4 25
-$15M
-$15M
Q1 26
-$15M
-$15M
Q2 26
-$16M
-$16M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q3 23
$40K
Q4 23
$37K
Q1 24
$185K
Q2 24
$19K
Q3 24
$41K
Q4 24
$86K
Q1 25
$53K
Q2 25
$53K
Q3 25
$125K
Q4 25
$287K
Q1 26
$349K
Q2 26
$133K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
-59.8%
-23.5%
Q2 23
-16.9%
-6.1%
Q3 23
-3.6%
-23.2%
Q4 23
-3.8%
-3.7%
Q1 24
+17.4%
+24.7%
Q2 24
-14.4%
-5.8%
Q3 24
-35.2%
+41.8%
Q4 24
-41.2%
+9.6%
Q1 25
-6.8%
+2.0%
Q2 25
-6.8%
+2.0%
Q3 25
+458.6%
+77.9%
Q4 25
+458.6%
+77.9%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q3 23
$791K
40.8%
Q4 23
$1M
51.8%
Q1 24
$1M
64.8%
Q2 24
$1M
64.8%
Q3 24
$0
0.0%
Q4 24
$0
0.0%
Q1 25
$0
0.0%
Q2 25
$8M
484.4%
Q3 25
$0
0.0%
Q4 25
$3M
49.3%
Q1 26
$0
—
Q2 26
$0
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
Quarter
R&D
G&A
S&M
Q1 23
$6M
$7M
$5M
Q2 23
$8M
$6M
$8M
Q3 23
$7M
$6M
$6M
Q4 23
$7M
$6M
$9M
Q1 24
$6M
$6M
—
Q2 24
$6M
$6M
—
Q3 24
$6M
$6M
—
Q4 24
$6M
$6M
—
Q1 25
$10M
$9M
—
Q2 25
$10M
$9M
—
Q3 25
$7M
$9M
$2M
Q4 25
$7M
$9M
$2M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q2 23
$67M
$0
$67M
Q3 23
$48M
$191K
$49M
Q4 23
$71M
$0
$71M
Q1 24
$78M
$0
$78M
Q2 24
$77M
$0
$77M
Q3 24
$63M
$0
$63M
Q4 24
$63M
$0
$63M
Q1 25
$38M
$0
$38M
Q2 25
$38M
$0
$38M
Q3 25
$162M
$0
$162M
Q4 25
$161M
$0
$161M
Q2 26
$130M
$0
$130M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
70M
+7.1%
Q2 23
77M
+10.7%
Q3 23
74M
-4.4%
Q4 23
94M
+27.9%
Q1 24
85M
-9.6%
Q2 24
85M
+0.0%
Q3 24
112M
+31.8%
Q4 24
112M
+0.0%
Q1 25
114M
+1.8%
Q2 25
114M
+0.0%
Q3 25
127M
+11.5%
Q4 25
127M
+0.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
—
—
FY 15
—
—
FY 16
$394K
108
FY 17
$32K
75
FY 18
$214K
81
FY 19
$201K
83
FY 20
$315K
102
FY 21
$90K
83
FY 22
$133K
77
FY 23
$90K
83
FY 24
$81K
73
FY 25
$212K
81
marketcaparena.com
